These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 16021460)

  • 1. Intratympanic gentamicin in monolateral Meniere's disease: our experience.
    Bertino G; Durso D; Manfrin M; Casati L; Mira E
    Eur Arch Otorhinolaryngol; 2006 Mar; 263(3):271-5. PubMed ID: 16021460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A; Aloisi A; De Benedittis G; Scaringi A
    Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF; Poe DS
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose intratympanic gentamicin administration for unilateral Meniere's disease using a method based on clinical symptomatology: Preliminary results.
    Scarpa A; Ralli M; Cassandro C; Gioacchini FM; Alicandri-Ciufelli M; Viola P; Chiarella G; de Vincentiis M; Cassandro E
    Am J Otolaryngol; 2019; 40(6):102289. PubMed ID: 31537428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA; Chen DA; Arriaga MA
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The long-term results of treatment of Ménière's disease with intratympanic injections of gentamicin].
    Gawęcki W; Szyfter W; Lączkowska-Przybylska J; Szyfter-Harris J
    Otolaryngol Pol; 2012; 66(1):20-6. PubMed ID: 22381010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial.
    Patel M; Agarwal K; Arshad Q; Hariri M; Rea P; Seemungal BM; Golding JF; Harcourt JP; Bronstein AM
    Lancet; 2016 Dec; 388(10061):2753-2762. PubMed ID: 27865535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N; Boleas MS; Martin E
    Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and preservation of hearing with low-dose gentamicin in unilateral meniere's disease: A clinical symptomatology-based study.
    Scarpa A; Avallone E; Carucci M; Salzano G; Chiarella G; Cassandro C; Viola P; Ricciardiello F; Ralli M; De Luca P; Salzano FA
    Am J Otolaryngol; 2024; 45(1):104116. PubMed ID: 37984050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy.
    Crane BT; Minor LB; Della Santina CC; Carey JP
    Otol Neurotol; 2009 Aug; 30(5):619-24. PubMed ID: 19503016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Ménière's disease with "on-demand" intratympanic gentamicin injections.
    Manrique-Huarte R; Guillén-Grima F; Perez-Fernandez N
    Otol Neurotol; 2011 Apr; 32(3):461-5. PubMed ID: 21317673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D; Wolf M; Kronenberg J
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.